• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

L-天冬酰胺酶治疗可降低蛋白C系统的抗凝潜力,而不影响维生素K依赖的羧化作用。

L-asparaginase treatment reduces the anticoagulant potential of the protein C system without affecting vitamin K-dependent carboxylation.

作者信息

Vigano'D'Angelo S, Gugliotta L, Mattioli Belmonte M, Cascione M L, Pattarini E, D'Angelo A

机构信息

Servizio di Coagulazione, IRCCS H.S.Raffaele, Milano, Italy.

出版信息

Thromb Res. 1990 Sep 15;59(6):985-94. doi: 10.1016/0049-3848(90)90122-s.

DOI:10.1016/0049-3848(90)90122-s
PMID:2148229
Abstract

The changes in plasma levels of the vitamin K-dependent natural anticoagulants protein C (PC) and protein S (PS) and procoagulant factors II, IX and X were evaluated in 8 adult patients during treatment with L-asparaginase (L-ase i.v. 120,000 U/m2 over 10 days). PC anticoagulant activity and factor IX, X and II coagulant activity decreased proportionally to their half-lives to a nadir of 50-60% of pretreatment values after 2-5 L-ase infusions, suggesting that inhibition of protein synthesis rather than consumption is the main mechanism responsible for the observed changes. Free PS antigen levels declined at a rate similar to total PS antigen, reaching a nadir of 56% of pretreatment values after 3 L-ase infusions; however due to C4b-binding protein levels higher than total PS levels (p less than 0.05), they were constantly lower than the corresponding total PS antigen levels (0.05 less than p less than 0.001). This implicates that total PS antigen levels cannot be taken as an indicator of PS activity. No differences between the antigenic levels and the anticoagulant activities of PC and free PS could be observed suggesting that L-ase does not affect the mechanisms of vitamin K-dependent carboxylation of Gla-residues. The faster rate of decline of PC and PS activities relative to that of factor II may be responsible for the onset of an hypercoagulable state during the early phase of L-ase treatment.

摘要

在8例成年患者接受L-天冬酰胺酶治疗(静脉注射L-天冬酰胺酶120,000 U/m²,持续10天)期间,评估了维生素K依赖性天然抗凝蛋白C(PC)和蛋白S(PS)以及促凝血因子II、IX和X的血浆水平变化。PC抗凝活性以及因子IX、X和II的凝血活性与其半衰期成比例下降,在2 - 5次L-天冬酰胺酶输注后降至预处理值的50 - 60%的最低点,这表明蛋白质合成受抑制而非消耗是导致观察到的变化的主要机制。游离PS抗原水平以与总PS抗原相似的速率下降,在3次L-天冬酰胺酶输注后降至预处理值的56%的最低点;然而,由于C4b结合蛋白水平高于总PS水平(p < 0.05),它们一直低于相应的总PS抗原水平(0.05 < p < 0.001)。这意味着总PS抗原水平不能作为PS活性的指标。未观察到PC和游离PS的抗原水平与抗凝活性之间存在差异,表明L-天冬酰胺酶不影响维生素K依赖性γ-羧基谷氨酸残基的羧化机制。PC和PS活性相对于因子II的下降速度更快,可能是L-天冬酰胺酶治疗早期高凝状态发生的原因。

相似文献

1
L-asparaginase treatment reduces the anticoagulant potential of the protein C system without affecting vitamin K-dependent carboxylation.L-天冬酰胺酶治疗可降低蛋白C系统的抗凝潜力,而不影响维生素K依赖的羧化作用。
Thromb Res. 1990 Sep 15;59(6):985-94. doi: 10.1016/0049-3848(90)90122-s.
2
Protein S and protein C anticoagulant activity in acute and chronic cardiac ischemic syndromes. Relationship to inflammation, complement activation and in vivo thrombin activity.急性和慢性心脏缺血综合征中蛋白S和蛋白C的抗凝活性。与炎症、补体激活及体内凝血酶活性的关系。
Thromb Res. 1994 Jul 15;75(2):133-42. doi: 10.1016/0049-3848(94)90062-0.
3
Effect of L-asparaginase therapy for acute lymphoblastic leukemia on plasma vitamin K-dependent coagulation factors and inhibitors.L-天冬酰胺酶治疗急性淋巴细胞白血病对血浆维生素K依赖的凝血因子及抑制剂的影响
J Pediatr. 1986 May;108(5 Pt 1):698-701. doi: 10.1016/s0022-3476(86)81044-7.
4
L-Asparaginase and the effect of age on coagulation and fibrinolysis in childhood acute lymphoblastic leukemia.左旋天冬酰胺酶与年龄对儿童急性淋巴细胞白血病凝血和纤维蛋白溶解的影响
Thromb Haemost. 2008 Aug;100(2):330-7.
5
Hypercoagulability during L-asparaginase treatment: the effect of antithrombin III supplementation in vivo.L-天冬酰胺酶治疗期间的高凝状态:体内补充抗凝血酶III的效果。
Br J Haematol. 1990 Apr;74(4):465-70. doi: 10.1111/j.1365-2141.1990.tb06336.x.
6
Interaction between interleukin-6 and the natural anticoagulant system in acute stroke.
J Interferon Cytokine Res. 2000 Mar;20(3):325-9. doi: 10.1089/107999000312478.
7
Chemotherapy induces enhanced procoagulant activity through phosphatidylserine exposure in acute lymphoblastic leukemia.化疗通过急性淋巴细胞白血病中磷脂酰丝氨酸的暴露诱导增强的促凝活性。
Thromb Res. 2013 Nov;132(5):614-20. doi: 10.1016/j.thromres.2013.09.010. Epub 2013 Sep 13.
8
Plasma protein S in disseminated intravascular coagulation, liver disease, collagen disease, diabetes mellitus, and under oral anticoagulant therapy.弥散性血管内凝血、肝脏疾病、胶原病、糖尿病及口服抗凝治疗时的血浆蛋白S
Clin Chim Acta. 1989 Jun 30;182(2):195-208. doi: 10.1016/0009-8981(89)90078-8.
9
A regimen for antithrombin III substitution in patients with acute lymphoblastic leukemia under treatment with L-asparaginase.在接受L-天冬酰胺酶治疗的急性淋巴细胞白血病患者中抗凝血酶III替代治疗方案。
Haematologica. 1991 May-Jun;76(3):209-14.
10
Erwinia- and E. coli-derived L-asparaginase have similar effects on hemostasis. Pilot study in 10 patients with acute lymphoblastic leukemia.欧文氏菌属和大肠杆菌衍生的L-天冬酰胺酶对止血有相似作用。对10例急性淋巴细胞白血病患者的初步研究。
Haematologica. 1993 Nov-Dec;78(6 Suppl 2):57-60.

引用本文的文献

1
Cancer Therapy-Associated Thrombosis.癌症治疗相关的血栓。
Arterioscler Thromb Vasc Biol. 2021 Apr;41(4):1291-1305. doi: 10.1161/ATVBAHA.120.314378. Epub 2021 Feb 11.